Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Caesars Entertainment explores sale offers, including a bid from billionaire Tilman Fertitta. With $20B+ debt and iconic Las Vegas properties like Caesars Palace, a major casino takeover could be in play despite ongoing challenges.
CMS resolves hypoglossal nerve stimulation reimbursement confusion by adding 6 new HCPCS codes (effective Jan 1, 2026), viewed as positive for Inspire & Nyxoah.
Sable Offshore shares drop after a California judge's preliminary ruling keeps an injunction on pipeline restart in place.
uniQure shares fell about 33% after FDA Commissioner Marty Makary's comments on rare disease drugs. But analysts say his remarks likely targeted another therapy, not uniQure's AMT-130 for Huntington's disease.
PayPal denies being in acquisition discussions with Stripe amid recent rumors. The company is preparing defenses against activists or takeovers after a stock drop, as new CEO Enrique Lores prepares to start.
AtaiBeckley (ATAI) tested an R-MDMA pill for social anxiety. Results looked promising — but the trial was tiny, just 6 weeks, and far from FDA approval.
